0000950123-20-004802.txt : 20200514 0000950123-20-004802.hdr.sgml : 20200514 20200514095307 ACCESSION NUMBER: 0000950123-20-004802 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 EFFECTIVENESS DATE: 20200514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Fund Management, LLC CENTRAL INDEX KEY: 0001637359 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16844 FILM NUMBER: 20875668 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: 888 BOYLSTON ST., SUITE 1111 CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: Omega Fund Management (US) Inc. DATE OF NAME CHANGE: 20150320 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001637359 XXXXXXXX 03-31-2020 03-31-2020 Omega Fund Management, LLC
888 Boylston St., Suite 1111 Boston MA 02199
13F HOLDINGS REPORT 028-16844 N
Anne-Mari Paster Chief Financial Officer, Omega Fund Management, LLC 617.502.6538 /s/ Anne-Mari Paster Boston MA 05-11-2020 0 16 241630 false
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Arcutis Biothereapeutics Common Stock 03969K108 25171 844680 SH SOLE 844680 0 0 Beam Therapeutics Common Stock 07373V105 5451 302821 SH SOLE 302821 0 0 Cidara Therapeutics Common Stock 171757107 4980 2008150 SH SOLE 2008150 0 0 ESSA Pharma Common Stock 29668H708 6759 1689848 SH SOLE 1689848 0 0 FibroGen Common Stock 31572Q808 4540 130646 SH SOLE 130646 0 0 Gossamer Bio Common Stock 38341P102 43399 4275726 SH SOLE 4275726 0 0 Immunic Common Stock 4525EP101 8298 1371494 SH SOLE 1371494 0 0 Jounce Therapeutics Common Stock 481116101 2517 529965 SH SOLE 529965 0 0 Morphic Holding Common Stock 61775R105 43593 2969582 SH SOLE 2969582 0 0 ObsEva Common Stock H5861P103 2408 999364 SH SOLE 999364 0 0 Paratek Pharmaceuticals Common Stock 699374302 8191 2600410 SH SOLE 2600410 0 0 Pieris Pharmaceuticals Common Stock 720795103 1712 750741 SH SOLE 750741 0 0 Prevail Therapeutics Common Stock 74140Y101 3326 272807 SH SOLE 272807 0 0 Replimune Group Common Stock 76029N106 52825 5323455 SH SOLE 5323455 0 0 Translate Bio Common Stock 89374L104 24303 2437603 SH SOLE 2437603 0 0 Trevi Therapeutics Common Stock 89532M101 4157 1263408 SH SOLE 1263408 0 0